0001042074-17-000008.txt : 20170630 0001042074-17-000008.hdr.sgml : 20170630 20170630131608 ACCESSION NUMBER: 0001042074-17-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170628 FILED AS OF DATE: 20170630 DATE AS OF CHANGE: 20170630 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dickinson Klara CENTRAL INDEX KEY: 0001339895 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36500 FILM NUMBER: 17941312 MAIL ADDRESS: STREET 1: 7999 GATEWAY BOULEVARD, SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-06-28 0 0001042074 CymaBay Therapeutics, Inc. CBAY 0001339895 Dickinson Klara 7999 GATEWAY BOULEVARD, SUITE 130 NEWARK CA 94560 0 1 0 0 SVP, Regulatory Affairs & QA Stock Option (right to buy) 5.5 2017-06-28 4 A 0 200000 0 A 2027-06-27 Common Stock 200000 200000 D The shares subject to the option shall vest according to the following schedule: 25% of the shares subject to the option shall vest on June 26, 2018, and the remaining of the shares shall vest in equal monthly installments over the next 36 months. /s/ Klara A. Dickinson-Eason 2017-06-29